Human embryonic stem cells: origin, properties and applications

被引:24
作者
Semb, H [1 ]
机构
[1] Lund Univ, Stem Cell Ctr, Lund, Sweden
关键词
human embryonic stem cells; origin; properties; clinical application;
D O I
10.1111/j.1600-0463.2005.apm_312.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Human embryonic stem cells originate from the human preimplantation embryo. The derivation of the first human embryonic stem cells was reported in 1998. Since then we have learnt a great deal about how to isolate and culture these cells. Additionally, their stem cell phenotype and differentiation competence have been determined. Although it is expected that many basic biological properties, such as self-renewal and cell specification, are evolutionary conserved, at least from the mouse, we lack significant knowledge about the molecular events that regulate the unique stem cell features of human embryonic stem cells. The pluripotent nature of human embryonic stem cells has attracted great interest in using them as a source of cells and tissues in cell therapy. Recent progress in human somatic cell nuclear transfer suggests that there may be a solution to the immunotolerance problems associated with the use of human embryonic stem cells in cell-replacement therapy. Thus, human embryonic stem cells supply the research community with unique research tools to study basic biological processes in human cells, model human genetic diseases and develop new cell-replacement therapies.
引用
收藏
页码:743 / 750
页数:8
相关论文
共 68 条
[1]   Unique gene expression signatures of independently-derived human embryonic stem cell lines [J].
Abeyta, MJ ;
Clark, AT ;
Rodriguez, RT ;
Bodnar, MS ;
Pera, RAR ;
Firpo, MT .
HUMAN MOLECULAR GENETICS, 2004, 13 (06) :601-608
[2]   Human feeder layers for human embryonic stem cells [J].
Amit, M ;
Margulets, V ;
Segev, H ;
Shariki, K ;
Laevsky, I ;
Coleman, R ;
Itskovitz-Eldor, J .
BIOLOGY OF REPRODUCTION, 2003, 68 (06) :2150-2156
[3]   No evidence for infection of human embryonic stem cells by feeder cell-derived murine leukemia viruses [J].
Amit, M ;
Winkler, ME ;
Menke, S ;
Brüning, E ;
Büscher, K ;
Denner, J ;
Haverich, A ;
Itskovitz-Eldor, J ;
Martin, U .
STEM CELLS, 2005, 23 (06) :761-771
[4]   Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture [J].
Amit, M ;
Carpenter, MK ;
Inokuma, MS ;
Chiu, CP ;
Harris, CP ;
Waknitz, MA ;
Itskovitz-Eldor, J ;
Thomson, JA .
DEVELOPMENTAL BIOLOGY, 2000, 227 (02) :271-278
[5]   Feeder layer- and serum-free culture of human embryonic stem cells [J].
Amit, M ;
Shariki, C ;
Margulets, V ;
Itskovitz-Eldor, J .
BIOLOGY OF REPRODUCTION, 2004, 70 (03) :837-845
[6]  
Andrews PW, 2005, NAT BIOTECHNOL, V23, P795, DOI 10.1038/nbt0705-798
[7]   Genetics of Type 2 diabetes [J].
Barroso, I .
DIABETIC MEDICINE, 2005, 22 (05) :517-535
[8]  
BEDDINGTON RSP, 1989, DEVELOPMENT, V105, P733
[9]   Purified allogeneic hematopoietic stem cell transplantation blocks diabetes pathogenesis in NOD mice [J].
Beilhack, GF ;
Scheffold, YC ;
Weissman, IL ;
Taylor, C ;
Jerabek, L ;
Burge, MJ ;
Masek, MA ;
Shizuru, JA .
DIABETES, 2003, 52 (01) :59-68
[10]   Gene expression in human embryonic stem cell lines: unique molecular signature [J].
Bhattacharya, B ;
Miura, T ;
Brandenberger, R ;
Mejido, J ;
Luo, YQ ;
Yang, AX ;
Joshi, BH ;
Ginis, I ;
Thies, RS ;
Amit, M ;
Lyons, I ;
Condie, BG ;
Itskovitz-Eldor, J ;
Rao, MS ;
Puri, RK .
BLOOD, 2004, 103 (08) :2956-2964